Lutz Asmus

Lutz Asmus is a licensed pharmacist by training with a PharmD from the University of Tuebingen, Germany, in the field of excipient characterization. He obtained his PhD in Pharmaceutical Sciences from the University of Geneva in Switzerland working on solubilization and controlled release applications. Prior to joining AbbVie as formulation lead for solid oral dosage units, he worked for Boehringer-Ingelheim developing sustained-release formulations for biological entities. On a global assignment, Lutz started a group for parenteral process development at AbbVie’s headquarter in Lake County, Illinois, in 2017. His group is responsible for the development and technology transfer of clinical and commercial drug product manufacturing processes. Furthermore, they perform clinical in-use studies in close alignment with the clinical study sites and are responsible for the dose preparation instructions. Lutz is also the drug product- and CMC-lead for several projects at the transition point between discovery and clinical development.